P. Kou

Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis

Guangwei Luo, Leiya Kou, P. Kou, 2022, Oxidative medicine and cellular longevity.

CD4+ T Lymphocytes, Especially Th2 Cells, Contribute to the Progress of Renal Fibrosis

Gang Xu, Yueqiang Li, G. Pei, 2012, American Journal of Nephrology.

Recent advances of mTOR inhibitors use in autosomal dominant polycystic kidney disease: is the road still open?

Shuang Wei, Fei Xiong, P. Kou, 2018, Current medicinal chemistry.

Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells

Gang Xu, Yong Ning, Rui Zeng, 2013, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

Magnetic resonance imaging in studying the therapeutic effect of iPSCs transplantation for experimental

Jingliang Cheng, Haiyun Qi, B. Song, 2014 .

Current Progress and Perspectives on Using Gold Compounds for the Modulation of Tumor Cell Metabolism

Shuang Wei, Leiya Kou, P. Kou, 2021, Frontiers in Chemistry.

Magnetic resonance imaging in studying the therapeutic effect of iPSCs transplantation for experimental ICH

Y. Li, X. Liu, Y. Wang, 2014 .

Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway

S. Rong, Gang Xu, Rui Zeng, 2011, Journal of molecular medicine.

Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway

S. Rong, Gang Xu, Min Han, 2012, Journal of Molecular Medicine.